140 related articles for article (PubMed ID: 30169842)
21. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia.
Rothbaum BO; Hodges LF; Kooper R; Opdyke D; Williford JS; North M
Am J Psychiatry; 1995 Apr; 152(4):626-8. PubMed ID: 7694917
[TBL] [Abstract][Full Text] [Related]
22. Association study of monoamine oxidase-A gene promoter polymorphism (MAOA-uVNTR) with self-reported anxiety and other psychopathological symptoms in a community sample of early adolescents.
Voltas N; Aparicio E; Arija V; Canals J
J Anxiety Disord; 2015 Apr; 31():65-72. PubMed ID: 25747527
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the Mobile Virtual Reality Self-Training for Overcoming a Fear of Heights.
Hong YJ; Kim HE; Jung YH; Kyeong S; Kim JJ
Cyberpsychol Behav Soc Netw; 2017 Dec; 20(12):753-761. PubMed ID: 29211504
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of treatments for acrophobia.
Arroll B; Wallace HB; Mount V; Humm SP; Kingsford DW
Med J Aust; 2017 Apr; 206(6):263-267. PubMed ID: 28359010
[TBL] [Abstract][Full Text] [Related]
25. The use of virtual reality in acrophobia research and treatment.
Coelho CM; Waters AM; Hine TJ; Wallis G
J Anxiety Disord; 2009 Jun; 23(5):563-74. PubMed ID: 19282142
[TBL] [Abstract][Full Text] [Related]
26. Effects of acute exercise on fear extinction in rats and exposure therapy in humans: Null findings from five experiments.
Jacquart J; Roquet RF; Papini S; Powers MB; Rosenfield D; Smits JAJ; Monfils MH
J Anxiety Disord; 2017 Aug; 50():76-86. PubMed ID: 28618306
[TBL] [Abstract][Full Text] [Related]
27. Deconstructing acrophobia: physiological and psychological precursors to developing a fear of heights.
Coelho CM; Wallis G
Depress Anxiety; 2010 Sep; 27(9):864-70. PubMed ID: 20821801
[TBL] [Abstract][Full Text] [Related]
28. Does fear extinction in the laboratory predict outcomes of exposure therapy? A treatment analog study.
Forcadell E; Torrents-Rodas D; Vervliet B; Leiva D; Tortella-Feliu M; Fullana MA
Int J Psychophysiol; 2017 Nov; 121():63-71. PubMed ID: 28893566
[TBL] [Abstract][Full Text] [Related]
29. Monoamine Oxidase A Gene Methylation and Its Role in Posttraumatic Stress Disorder: First Evidence from the South Eastern Europe (SEE)-PTSD Study.
Ziegler C; Wolf C; Schiele MA; Feric Bojic E; Kucukalic S; Sabic Dzananovic E; Goci Uka A; Hoxha B; Haxhibeqiri V; Haxhibeqiri S; Kravic N; Muminovic Umihanic M; Cima Franc A; Jaksic N; Babic R; Pavlovic M; Warrings B; Bravo Mehmedbasic A; Rudan D; Aukst-Margetic B; Kucukalic A; Marjanovic D; Babic D; Bozina N; Jakovljevic M; Sinanovic O; Avdibegovic E; Agani F; Dzubur-Kulenovic A; Deckert J; Domschke K
Int J Neuropsychopharmacol; 2018 May; 21(5):423-432. PubMed ID: 29186431
[TBL] [Abstract][Full Text] [Related]
30. CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?
Schartner C; Ziegler C; Schiele MA; Kollert L; Weber H; Zwanzger P; Arolt V; Pauli P; Deckert J; Reif A; Domschke K
Eur Neuropsychopharmacol; 2017 Apr; 27(4):360-371. PubMed ID: 28233670
[TBL] [Abstract][Full Text] [Related]
31. Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder.
Dammann G; Teschler S; Haag T; Altmüller F; Tuczek F; Dammann RH
Epigenetics; 2011 Dec; 6(12):1454-62. PubMed ID: 22139575
[TBL] [Abstract][Full Text] [Related]
32. Cross-Sectional Survey of Mental Health Risk Factors and Comparison of the
Jiang T; Li X; Ning L; Liu J
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878203
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms, genes and treatment: Experimental fear conditioning, the serotonin transporter gene, and the outcome of a highly standardized exposure-based fear treatment.
Wannemueller A; Moser D; Kumsta R; Jöhren HP; Adolph D; Margraf J
Behav Res Ther; 2018 Aug; 107():117-126. PubMed ID: 29960126
[TBL] [Abstract][Full Text] [Related]
34. Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia.
Emmelkamp PM; Krijn M; Hulsbosch AM; de Vries S; Schuemie MJ; van der Mast CA
Behav Res Ther; 2002 May; 40(5):509-16. PubMed ID: 12038644
[TBL] [Abstract][Full Text] [Related]
35. MAOA methylation is associated with nicotine and alcohol dependence in women.
Philibert RA; Gunter TD; Beach SR; Brody GH; Madan A
Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):565-70. PubMed ID: 18454435
[TBL] [Abstract][Full Text] [Related]
36. Classification and Analysis of Human Body Movement Characteristics Associated with Acrophobia Induced by Virtual Reality Scenes of Heights.
Cheng X; Bao B; Cui W; Liu S; Zhong J; Cai L; Yang H
Sensors (Basel); 2023 Jun; 23(12):. PubMed ID: 37420652
[TBL] [Abstract][Full Text] [Related]
37. Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.
Trautmann S; Richter J; Muehlhan M; Höfler M; Wittchen HU; Domschke K; Ströhle A; Hamm AO; Weber H; Kircher T; Arolt V; Gerlach AL; Alpers GW; Fydrich T; Lang T; Reif A
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):161-170. PubMed ID: 28712090
[TBL] [Abstract][Full Text] [Related]
38. Evidence for interplay between genes and maternal stress in utero: monoamine oxidase A polymorphism moderates effects of life events during pregnancy on infant negative emotionality at 5 weeks.
Hill J; Breen G; Quinn J; Tibu F; Sharp H; Pickles A
Genes Brain Behav; 2013 Jun; 12(4):388-96. PubMed ID: 23480342
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acrophobia in virtual reality: the role of immersion and presence.
Krijn M; Emmelkamp PM; Biemond R; de Wilde de Ligny C; Schuemie MJ; van der Mast CA
Behav Res Ther; 2004 Feb; 42(2):229-39. PubMed ID: 14975783
[TBL] [Abstract][Full Text] [Related]
40. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
